The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts
References
1. http://www.roszdravnadzor.ru/news/14538
2. http://grls.rosminzdrav.ru/GRLS.aspxRegNumber=&MnnR=%d0%92%d0%b0%d0%bb%d1%81%d0%b0%d1%80%d1%82%d0%b0%d0%bd&lf=&TradeNmR=&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0&isND=-1®type=&pageSize=10&order=RegDate&orderType=desc&pageNum=1
3. http://roszdravnadzor.ru/i/upload/images/2018/10/17/1539794804.61052-1-17367.pdf
4. https://www.krka.biz/ru/media-tsentr/novosti/valsartan-ghruppy-kompanii-krka-nie-nbsp-sodierzhitndma-i-nbsp-ostaietsia-dostupnym-na-nbsp-rynkie-biez-kakikh-libo-oghranichienii/11325/
Review
For citations:
The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts. Rational Pharmacotherapy in Cardiology. 2018;14(6):959.
Views:
387
Email this article 